VCPIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.713400E-01
Normal-vs-Stage2
4.589000E-01
Normal-vs-Stage3
2.402400E-01
Normal-vs-Stage4
5.894400E-01
Stage1-vs-Stage2
9.940400E-01
Stage1-vs-Stage3
6.158400E-02
Stage1-vs-Stage4
6.565600E-01
Stage2-vs-Stage3
8.469800E-02
Stage2-vs-Stage4
5.372000E-01
Stage3-vs-Stage4
1.995230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.364000E-01
Normal-vs-AfricanAmerican
4.509600E-01
Normal-vs-Asian
1.502820E-01
Caucasian-vs-AfricanAmerican
4.562000E-01
Caucasian-vs-Asian
4.508200E-01
AfricanAmerican-vs-Asian
3.777600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.806400E-02
Normal-vs-Female
4.639600E-01
Male-vs-Female
6.416200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.997200E-01
Normal-vs-Age(41-60Yrs)
5.236600E-01
Normal-vs-Age(61-80Yrs)
7.790000E-02
Normal-vs-Age(81-100Yrs)
3.559600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.686400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.911400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.341200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.464840E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.913800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.291600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.875600E-01
Normal-vs-Daily Drinker
1.185000E-01
Normal-vs-Weekly Drinker
8.669900E-02
Normal-vs-Occasional Drinker
3.409000E-01
Normal-vs-Social Drinker
2.376200E-01
Non Drinker-vs-Daily Drinker
9.741800E-01
Non Drinker-vs-Weekly Drinker
8.537400E-01
Non Drinker-vs-Occasional Drinker
2.361800E-01
Non Drinker-vs-Social Drinker
2.041200E-01
Daily Drinker-vs-Weekly Drinker
9.146200E-01
Daily Drinker-vs-Occasional Drinker
2.907200E-01
Daily Drinker-vs-Social Drinker
3.399000E-01
Weekly Drinker-vs-Occasional Drinker
2.705000E-01
Weekly Drinker-vs-Social Drinker
2.734000E-01
Occasional Drinker-vs-Social Drinker
8.837000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.572190E-01
Normal-vs-Grade 2
1.817700E-02
Normal-vs-Grade 3
2.523500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.172400E-01
Grade 1-vs-Grade 3
2.576000E-01
Grade 1-vs-Grade 4
1.572190E-01
Grade 2-vs-Grade 3
5.935400E-01
Grade 2-vs-Grade 4
1.817700E-02
Grade 3-vs-Grade 4
2.523500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.493800E-02
Normal-vs-NonDiabetic
6.393800E-02
Diabetic-vs-NonDiabetic
8.914600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.785000E-01
Normal-vs-NoPancreatitis
7.855700E-02
Pancreatitis-vs-NoPancreatitis
5.058200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.548400E-02
Normal-vs-N1
4.782600E-01
N0-vs-N1
2.312400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.074200E-01
Normal-vs-TP53-NonMutant
4.375000E-01
TP53-Mutant-vs-TP53-NonMutant
1.526160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
